NCT04198883View on ClinicalTrials.gov

SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand)

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 27, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

July 31, 2021

Conditions
Heart Attack
Interventions
COMBINATION_PRODUCT

Protheracytes

Intramyocardiac (LV) injection of stem cells with a dedicated catheter

Trial Locations (1)

169609

NHCS, Singapore

Sponsors

Lead Sponsor

CellProthera
All Listed Sponsors
lead

CellProthera

INDUSTRY